Guo Tingting, Liu Lei, Zeng Lingyan, Yang Ying, Song Tingting, Zhao Huachang, Qiu Zhixin
Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China.
Department of Respiratory and Critical Care Medicine, The Fourth People's Hospital of Chengdu, No. 8 Huli-West 1st-Alley, Jin-Niu District, Chengdu, Sichuan, 610041, PR China.
Cell Oncol (Dordr). 2025 Jun 11. doi: 10.1007/s13402-025-01078-1.
Non-small cell lung cancer (NSCLC) mainly includes lung squamous cell carcinoma and lung adenocarcinoma, and its extremely high morbidity and mortality are the main causes of poor prognosis in NSCLC patients. Therefore, it is particularly important to study the mechanisms associated with tumor proliferation and metastasis and explore new molecular targets of NSCLC. Studies have shown that Guanosine monophosphate synthase (GMPS) may serve as a potential drug target, but its biological function and molecular mechanism in NSCLC are still unknown. Therefore, it is urgently needed to investigate the molecular mechanisms of GMPS.
We first analyzed 30 cases of lung adenocarcinoma, lung squamous carcinoma and adjacent tissues; Then, lentiviral technology was used to construct overexpressed or knocked out cell lines to verify the function of GMPS. Then, RNA sequencing and Western blot experiments were carried out in animal experiments to explore the mechanism of GMPS. Our experimental results suggest that GMPS plays an important role in the progression of NSCLC.
We found that GMPS was highly expressed in lung adenocarcinoma and lung squamous cell carcinoma tissues, and was associated with poor prognosis of patients. Down-regulation of GMPS inhibits tumor progression. And GMPS promotes lung cancer cell migration through the SERPINB2-uPA axis, and DNMT1 is an intermediate factor in GMPS regulating SERPINB2 expression. Our experimental results show that GMPS expression is associated with lung cancer invasion and migration.
Our findings revealed the correlation between GMPS and the prognosis of NSCLC at the tissue level. Secondly, GMPS can promote the progression of NSCLC. The molecular mechanism of GMPS affecting the metastasis of lung cancer cells was elucidated. These findings highlight the important role of GMPS in NSCLC, so as to provide new insights for the identification of new targets and lay a theoretical foundation for the clinical application of GMPS.
非小细胞肺癌(NSCLC)主要包括肺鳞状细胞癌和肺腺癌,其极高的发病率和死亡率是NSCLC患者预后不良的主要原因。因此,研究与肿瘤增殖和转移相关的机制并探索NSCLC的新分子靶点尤为重要。研究表明,鸟苷单磷酸合成酶(GMPS)可能是一个潜在的药物靶点,但其在NSCLC中的生物学功能和分子机制仍不清楚。因此,迫切需要研究GMPS的分子机制。
我们首先分析了30例肺腺癌、肺鳞癌及癌旁组织;然后,利用慢病毒技术构建过表达或敲除细胞系以验证GMPS的功能。接着,在动物实验中进行RNA测序和蛋白质印迹实验以探索GMPS的作用机制。我们的实验结果表明GMPS在NSCLC进展中起重要作用。
我们发现GMPS在肺腺癌和肺鳞状细胞癌组织中高表达,且与患者的不良预后相关。GMPS的下调抑制肿瘤进展。并且GMPS通过丝氨酸蛋白酶抑制剂B2(SERPINB2)-尿激酶型纤溶酶原激活剂(uPA)轴促进肺癌细胞迁移,而DNA甲基转移酶1(DNMT1)是GMPS调节SERPINB2表达的中间因子。我们的实验结果表明GMPS表达与肺癌侵袭和迁移相关。
我们的研究结果揭示了GMPS与NSCLC预后在组织水平上的相关性。其次,GMPS可促进NSCLC的进展。阐明了GMPS影响肺癌细胞转移的分子机制。这些发现突出了GMPS在NSCLC中的重要作用,从而为新靶点的鉴定提供新见解,并为GMPS的临床应用奠定理论基础。